Stock Research: Diagnósticos da América

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Diagnósticos da América

BOVESPA:DASA3 BRDASAACNOR1
30
  • Value
    68
  • Growth
    57
  • Safety
    Safety
    32
  • Combined
    59
  • Sentiment
    14
  • 360° View
    360° View
    30
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Diagnosticos da America SA (DASA) is a Brazil-based company providing diagnostic support services. Its main businesses include clinical analyses, diagnostic imaging, laboratory support for small and medium-sized laboratories, and auxiliary diagnostic support for the public health sector via the CientificaLab brand. The company primarily operates in Brazil and also engages in food and substance testing, import of medical equipment, and business franchising. In the last fiscal year, the company had a market cap of $287 million, profits of $679 million, and revenue of $2480 million.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
68 83 80 81
Growth
57 17 11 15
Safety
Safety
32 24 28 8
Sentiment
14 1 10 79
360° View
360° View
30 10 8 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
27 11 31 57
Opinions Change
74 50 29 50
Pro Holdings
n/a 12 8 28
Market Pulse
7 4 22 95
Sentiment
14 1 10 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
68 83 80 81
Growth
57 17 11 15
Safety Safety
32 24 28 8
Combined
59 24 23 12
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
95 95 65 69
Price vs. Earnings (P/E)
97 100 100 91
Price vs. Book (P/B)
86 97 85 73
Dividend Yield
29 67 44 60
Value
68 83 80 81
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
10 17 22 96
Profit Growth
92 67 4 6
Capital Growth
9 49 79 11
Stock Returns
97 1 11 1
Growth
57 17 11 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
4 2 4 4
Refinancing
83 100 83 41
Liquidity
15 10 12 14
Safety Safety
32 24 28 8

Similar Stocks

Discover high‑ranked alternatives to Diagnósticos da América and broaden your portfolio horizons.

Vodacom

JSE:VOD
Country: South Africa
Industry: Wireless Telecommunication
Size: X-Large
Full Stock Analysis

Lojas Renner

BOVESPA:LREN3
Country: Brazil
Industry: Apparel Retail
Size: Medium
Full Stock Analysis

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Fleury

BOVESPA:FLRY3
Country: Brazil
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This is a mixed bag with good value and high growth balanced by risky financing and negative sentiment. This is a risky stock that requires conviction; you should only consider it if you are willing to conduct further research into the underlying sentiment and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: